Biotech company needs your help with advance research.
Vir Biotechnology is looking for patients in San Diego and Los Angeles counties who have recovered from COVID-19 to donate blood to help
the company find better ways to diagnose and treat the infection.
With more than 40,000 ongoing global clinical trials, COVID-19 will cause immense delays with the advancement of research. For non-invasive biospecimen studies and clinical trials that require test subjects to visit hospitals or clinics for biospecimen collection, will the patients just stop showing up for collection?
Biobanks allow researchers to store and study human tissue for a variety of uses, including biomarker discovery, immunotherapy, and targeted treatment of diseases. To be useful, biobanks rely on the collection of samples, efficient isolation, production workflows, and sophisticated data mining tools to access the information and specimens once they’ve been collected and stored.
Intense competition in the genomic-sequencing space continues, but not at a level that once fueled the field. Could progress in sequencing tools and research overseas help democratization of sequencing in the United States?
The $1,000 genome—or even the $100 genome—could be closer to becoming a reality than ever before.
